本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytek BioSciences

5.49
-0.0100-0.18%
成交量:266.83万
成交额:1,528.43万
市值:7.02亿
市盈率:-51.04
高:6.18
开:6.18
低:5.43
收:5.50
52周最高:7.30
52周最低:2.37
股本:1.28亿
流通股本:1.09亿
量比:3.94
换手率:2.45%
股息:- -
股息率:- -
每股收益(TTM):-0.1076
每股收益(LYR):-0.0461
净资产收益率:-3.36%
总资产收益率:-4.36%
市净率:1.85
市盈率(LYR):-119.11

数据加载中...

2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report